Skip to main content

Want a detailed portfolio tracker?

Performance analysis of ReShape Lifesciences (HIND)

Annual Return

Over the past 3 years, HIND has had an average annual return of -50.00%, underperforming the benchmark SPY, which returned +19.62% annual.

Over the past 5 years, HIND has had an average annual return of -90.67%, underperforming the benchmark SPY, which returned +12.73% annual.

Since Oct 6, 2016, HIND has had an average annual return of -72.23%, underperforming the benchmark SPY, which returned +15.36% annual.

20232022202120202019201820172016
-88.89%-91.74%+9%-21.26%-90.80%-68.69%-25.31%-41.00%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2023+11.11%-40.00%-50.00%+0%+0%-33.33%+0%-50.00%+0%+0%-88.89%
2022-22.02%-14.12%+8.22%-27.85%+17.54%-43.28%-15.79%-12.50%-28.57%-0%-50.00%-10.00%-91.74%
2021+200%-23.67%-17.90%-5.85%+17.51%+60.10%-20.42%-12.83%-16.88%-5.73%-30.39%-13.49%+9%
2020-8.66%-19.83%-48.39%+20.83%+12.07%-27.69%-4.26%+26.67%+7.02%+8.20%-7.58%+63.93%-21.26%
2019-11.59%-1.64%-20.00%-68.65%+190.03%-46.62%-25.54%-60.52%-5.84%-13.18%+8.04%+4.96%-90.80%
2018-37.99%-1.94%-14.66%+12.24%-34.55%-14.70%-22.75%+74.07%-6.59%-25.00%-18.00%+24.66%-68.69%
2017+14.36%-7.91%+14.71%-0.66%-12.53%+6.68%-14.23%+5.75%+6.01%-11.54%-2.37%-19.68%-25.31%

Drawdown analysis of ReShape Lifesciences (HIND)

The maximum drawdown for the HIND was -99.99%, occurring on Aug 25, 2023. This drawdown has not yet recovered.

The current HIND drawdown is -99.99%.

Since Oct 6, 2016 HIND has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 1 time
  • 20% or more: 1 time
  • 10% or more: 1 time
DepthStartTo BottomBottomTo RecoverEndTotal
-99.99%Oct 6, 20161732Aug 25, 2023OngoingOngoingOngoing